Nice try. I own 1000s of shares and have been in this 10+ years. Started investing in stocks in 1995 so hardly new to investing, but Im happy to state facts here to show your posts are false. This is a biotechnology homerun, you have no idea what you are playing with if you are short this one. I'm also an MD and understand phase 3 trial endpoints like this one are huge. I also understand how Ovarian CA presents in late stages and is very hard to treat. Not a lot out there that is great for ovarian cancer so this is a very significant result that will be jumped on immediately by physicians who are treating Ovarian cancer.
News 
Market Data 
Discover 
AI
